Starpharma (ASX SPL) granted marketing approval for condom in Europe

[videojs_hls url=’//du7x25at22z7c.cloudfront.net/274556/index_HLSv3.m3u8′ poster=’http://www.finnewsnetwork.com.au/newssystem/Headlines02_360_191121.jpg’]

Starpharma (ASX SPL) has been granted marketing approval for the VivaGel® condom in Europe.

It is the only condom of its type incorporating the proprietary compound, astodrimer sodium (SPL7013, VivaGel®) in the condom lubricant.

The European approval applies to all 28 member states of the European Union, including the United Kingdom, a total population of approximately 525 million people.

Starpharma’s marketing partner in Europe, LifeStyles (formerly Ansell) will now undertake marketing preparations ahead of the launch under the brand name Absolute™ DUAL PROTECTION.

The VivaGel® condom is also approved for sale in Japan, Canada and Australia.

Shares in Starpharma (ASX SPL) closed 1.54 per cent higher at $1.32
 
Copyright 2019 – Finance News Network

Source: Finance News Network